Change of the growth hormone–insulin-like growth factor-I axis in patients with gastrointestinal cancer: related to tumour type and nutritional status

No abstract is available for this paper.

• Publication year

  2005

• Venue

  British Journal of Nutrition

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1079/BJN20051412PMID 16022754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The inhibition of growth hormone secretion presented in obesity is not mediated by the high leptin levels: a study in human leptin deficiency patients.

  2003cited by this paper
• Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa.

  2003cited by this paper
• Molecular-based therapeutic approaches in treatment of anorexia of aging and cancer cachexia.

  2002cited by this paper
• Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity.

  2002cited by this paper
• Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition?

  2002cited by this paper
• Regulation of human growth hormone secretion and its disorders.

  2002cited by this paper
• Cancer cachexia.

  2002cited by this paper
• Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure.

  2001cited by this paper
• Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.

  2001cited by this paper
• Nutritional support of the cancer patient: issues and dilemmas.

  2000cited by this paper
• Metabolic abnormalities in cachexia and anorexia.

  2000cited by this paper
• Growth hormone therapy in adults and children.

  1999cited by this paper
• Cancer cachexia.

  1999cited by this paper
• Improving Nature? The Science and Ethics of Genetic Engineering

  1997cited by this paper
• Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep.

  1996cited by this paper
• The lack of an effect by insulin or insulin-like growth factor-1 in attenuating colon-2-mediated cancer cachexia.

  1996cited by this paper
• Acquired growth hormone resistance.

  1995cited by this paper
• Growth hormone in HIV/AIDS: current uses and future prospects.

  1995influential reference
• Restoration of growth hormone secretion in prolonged food-deprived rats depends on the level of nutritional intake and dietary protein.

  1994cited by this paper
• Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome.

  1994influential reference
• Acquired growth hormone resistance in patients with hypercatabolism.

  1993cited by this paper
• Normal control of growth hormone secretion.

  1993cited by this paper
• Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men.

  1992cited by this paper
• Passive immunization against circulating insulin-like growth factor-I (IGF-I) increases protein catabolism in lambs: evidence for a physiological role for circulating IGF-I.

  1992cited by this paper
• Catabolic illness. Strategies for enhancing recovery.

  1991cited by this paper
• Growth Hormone Secretion: Its Regulation and the Influence of Nutritional Factors

  1990cited by this paper
• Reduction of plasma immunoreactive somatomedin C during fasting in humans.

  1981cited by this paper
• Textbook of Medical Physiology

  1961cited by this paper

• Circulating protein levels of insulin-like growth factor 1 signaling pathway and the predisposition to colorectal carcinogenesis: a systematic review and meta-analysis

  2025influential citation
• Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancer

  2024cites this paper
• The Role of Insulin-Like Growth Factor 1 in Delirium: A Systematic Review and Meta-Analysis

  2023cites this paper
• Association of IGF‐1 and IGFBP‐3 levels with gastric cancer: A systematic review and meta‐analysis

  2021cites this paper
• Hormones and Muscle Atrophy.

  2018cites this paper
• Cancer-associated cachexia

  2018cites this paper
• Cancer cachexia: Diagnosis, assessment, and treatment.

  2018cites this paper
• Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance

  2015cites this paper
• Miopatia subclinica in pazienti con neoplasia del colon-retto: caratterizzazione clinico-patologica e ricerca di marcatori tessutali di miopatia

  2012cites this paper
• Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis.

  2011cites this paper
• Disturbance of the growth hormone-insulin-like growth factor-1 axis associated with poor performance status in patients with solid tumors.

  2010cites this paper
• Adipokines and ghrelin in gastric cancer cachexia.

  2008cites this paper
• GROWTH HORMONE GENES AND PROSTATE CANCER RISK

  2007cites this paper
• Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia.

  2007cites this paper
• Circulating Ghrelin in Patients with Gastric or Colorectal Cancer

  2007cites this paper
• Central mechanisms controlling appetite and food intake in a cancer setting: an update

  2007cites this paper
• Cancer-associated cachexia and underlying biological mechanisms.

  2006cites this paper
• Insight into the growth hormone–insulin-like growth factor-I axis in cancer cachexia

  2005cites this paper